What's new in prostate cancer screening and prevention?

被引:6
|
作者
Klein, Eric A. [1 ,2 ]
机构
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
关键词
TRIAL; ANTIGEN; RISK; MEN; MORTALITY;
D O I
10.3949/ccjm.76a.02009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prostate cancer is extremely common but causes death in only a minority of men in whom it develops, facts that raise issues regarding screening and treatment morbidity. Two large trials of screening with prostate-specific antigen (PSA) measurements came to seemingly opposite conclusions. Furthermore; a large trial of selenium and vitamin E found that these agents have no value as preventive agents.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 50 条